Loading clinical trials...
Loading clinical trials...
Efficacy & Safety of SmofKabiven Peripheral vs Compounded Emulsion: A Randomized, Active-Controlled, Open-Labelled, Multi-Centre Study in Adult Surgical Patients Requiring Parenteral Nutrition
Conditions
Interventions
SmofKabiven Peripheral
Hospital compounded emulsion
Locations
5
China
Beijing Friendship Hospital Capital Medical University
Beijing, China
Peking University People's Hospital
Beijing, China
The First Affiliated Hospital with Nanjing Medical University
Nanjing, China
The Affiliated Hospital of Qingdao University
Qingdao, China
Zhongshan Hospital, Fudan University
Shanghai, China
Start Date
December 21, 2017
Primary Completion Date
December 30, 2018
Completion Date
December 30, 2018
Last Updated
August 2, 2021
NCT05128890
NCT06409156
NCT04246463
NCT07465510
NCT06243848
NCT07464600
Lead Sponsor
Fresenius Kabi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions